Royal DSM N.V. has announced that privately owned Pentapharm Holding Ltd. and DSM Nutritional Products Ltd have signed an agreement on the sale and purchase of 100% of the Pentapharm’s shares to DSM. The parties have agreed not to disclose financial details of the transaction.
Pentapharm, headquartered in Basel, Switzerland, has annual sales revenues of around EUR40 million and employs 200 staff in locations in Switzerland, Brazil and Japan.
Pentapharm holds a global leading position in the development and production of active ingredients and system solutions for the cosmetics industry and is also present in niche pharmaceutical and diagnostics markets.
Pentapharm’s patent-protected cosmetic active ingredients range includes Erythrulose for self-tanning, Syn-Ake, an anti-wrinkle synthetic tripeptide, and Vialox, an effective topical alternative to botox injections against expression lines. Supported by the global wellness trend such cosmetic active ingredients benefit from the highest growth rates within the personal care ingredients market. In the pharmaceutical and diagnostics field Pentapharm offers specialised products for niche applications in the context of human blood coagulation disorders.
With the acquisition of Pentapharm, DSM Nutritional Products will further strengthen its position as the global leading supplier of active ingredients for skin and sun care, the company said.
Krijn Rietveld, senior vice president and head of new business development, DSM Nutritional Products, said: “We are very pleased with this acquisition, as it further enriches our existing Personal Care portfolio of vitamins and sun-filters with highly specialised actives based on innovative technologies. Pentapharm’s products and brands are well-positioned and are an attractive platform for launching some of the new products we have in the pipeline.”
Stephan Tanda, member of the managing board of DSM and responsible for the Nutrition Cluster of DSM, added: "This is a great step in boosting our innovation potential in personal care, one of the key areas we are committed to build in order to achieve the ambitious growth targets set out in our Vision 2010 strategy."
